Tuberculose ultrarésistante aux médicaments : Questions médicales fréquentes
Nom anglais: Extensively Drug-Resistant Tuberculosis
Descriptor UI:D054908
Tree Number:C01.150.252.410.040.552.846.775.500
Termes MeSH sélectionnés :
Linear Models
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Tuberculose ultrarésistante aux médicaments : Questions médicales les plus fréquentes",
"headline": "Tuberculose ultrarésistante aux médicaments : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Tuberculose ultrarésistante aux médicaments : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-02-05",
"dateModified": "2025-04-30",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Tuberculose ultrarésistante aux médicaments"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Tuberculose multirésistante",
"url": "https://questionsmedicales.fr/mesh/D018088",
"about": {
"@type": "MedicalCondition",
"name": "Tuberculose multirésistante",
"code": {
"@type": "MedicalCode",
"code": "D018088",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C01.150.252.410.040.552.846.775"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Tuberculose ultrarésistante aux médicaments",
"alternateName": "Extensively Drug-Resistant Tuberculosis",
"code": {
"@type": "MedicalCode",
"code": "D054908",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Peize Zhang",
"url": "https://questionsmedicales.fr/author/Peize%20Zhang",
"affiliation": {
"@type": "Organization",
"name": "Pulmonary Medicine and Tuberculosis, The Third People's Hospital of Shenzhen, The National Clinical Research Center for Infectious Diseases, Shenzhen, China."
}
},
{
"@type": "Person",
"name": "Guofang Deng",
"url": "https://questionsmedicales.fr/author/Guofang%20Deng",
"affiliation": {
"@type": "Organization",
"name": "Pulmonary Medicine and Tuberculosis, The Third People's Hospital of Shenzhen, The National Clinical Research Center for Infectious Diseases, Shenzhen, China."
}
},
{
"@type": "Person",
"name": "Nam Xuan Vo",
"url": "https://questionsmedicales.fr/author/Nam%20Xuan%20Vo",
"affiliation": {
"@type": "Organization",
"name": "Graduate Program in Social, Economic and Administrative Pharmacy, Department of Pharmacy, Faculty of Pharmacy, Mahidol University, Bangkok 10400, Thailand."
}
},
{
"@type": "Person",
"name": "Trung Quang Vo",
"url": "https://questionsmedicales.fr/author/Trung%20Quang%20Vo",
"affiliation": {
"@type": "Organization",
"name": "Department of Economic and Administrative Pharmacy (EAP), Faculty of Pharmacy, Pham Ngoc Thach University of Medicine, Ho Chi Minh City 700000, Vietnam."
}
},
{
"@type": "Person",
"name": "Getu Diriba",
"url": "https://questionsmedicales.fr/author/Getu%20Diriba",
"affiliation": {
"@type": "Organization",
"name": "Ethiopian Public Health Institute, Addis Ababa, Ethiopia. Electronic address: getud2020@gmail.com."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Asynchronous functional linear regression models for longitudinal data in reproducing kernel Hilbert space.",
"datePublished": "2022-10-17",
"url": "https://questionsmedicales.fr/article/36205584",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/biom.13767"
}
},
{
"@type": "ScholarlyArticle",
"name": "A multivariate analysis to propose linear models for the stature estimation in the Sabahan young adult population.",
"datePublished": "2022-08-30",
"url": "https://questionsmedicales.fr/article/36040989",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1371/journal.pone.0273840"
}
},
{
"@type": "ScholarlyArticle",
"name": "Analytical results for directional and quadratic selection gradients for log-linear models of fitness functions.",
"datePublished": "2022-05-18",
"url": "https://questionsmedicales.fr/article/35340021",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/evo.14486"
}
},
{
"@type": "ScholarlyArticle",
"name": "A novel hybrid random forest linear model approach for forecasting groundwater fluoride contamination.",
"datePublished": "2023-02-17",
"url": "https://questionsmedicales.fr/article/36800089",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s11356-023-25886-w"
}
},
{
"@type": "ScholarlyArticle",
"name": "A Connection Between Pattern Classification by Machine Learning and Statistical Inference With the General Linear Model.",
"datePublished": "2022-11-10",
"url": "https://questionsmedicales.fr/article/34347610",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1109/JBHI.2021.3101662"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Infection",
"item": "https://questionsmedicales.fr/mesh/D007239"
},
{
"@type": "ListItem",
"position": 3,
"name": "Infections bactériennes et mycoses",
"item": "https://questionsmedicales.fr/mesh/D001423"
},
{
"@type": "ListItem",
"position": 4,
"name": "Infections bactériennes",
"item": "https://questionsmedicales.fr/mesh/D001424"
},
{
"@type": "ListItem",
"position": 5,
"name": "Infections bactériennes à Gram positif",
"item": "https://questionsmedicales.fr/mesh/D016908"
},
{
"@type": "ListItem",
"position": 6,
"name": "Infections à Actinomycetales",
"item": "https://questionsmedicales.fr/mesh/D000193"
},
{
"@type": "ListItem",
"position": 7,
"name": "Infections à Mycobacterium",
"item": "https://questionsmedicales.fr/mesh/D009164"
},
{
"@type": "ListItem",
"position": 8,
"name": "Tuberculose",
"item": "https://questionsmedicales.fr/mesh/D014376"
},
{
"@type": "ListItem",
"position": 9,
"name": "Tuberculose multirésistante",
"item": "https://questionsmedicales.fr/mesh/D018088"
},
{
"@type": "ListItem",
"position": 10,
"name": "Tuberculose ultrarésistante aux médicaments",
"item": "https://questionsmedicales.fr/mesh/D054908"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Tuberculose ultrarésistante aux médicaments - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Tuberculose ultrarésistante aux médicaments",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-04",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Tuberculose ultrarésistante aux médicaments",
"description": "Comment diagnostiquer la XDR-TB ?\nQuels tests sont utilisés pour la XDR-TB ?\nQuels symptômes indiquent une XDR-TB ?\nLa radiographie est-elle utile pour la XDR-TB ?\nPeut-on détecter la XDR-TB par un test rapide ?",
"url": "https://questionsmedicales.fr/mesh/D054908?mesh_terms=Linear+Models&page=5#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Tuberculose ultrarésistante aux médicaments",
"description": "Quels sont les symptômes principaux de la XDR-TB ?\nLa douleur thoracique est-elle un symptôme ?\nLes sueurs nocturnes sont-elles fréquentes ?\nLa fatigue est-elle un symptôme de la XDR-TB ?\nPeut-on avoir des symptômes gastro-intestinaux ?",
"url": "https://questionsmedicales.fr/mesh/D054908?mesh_terms=Linear+Models&page=5#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Tuberculose ultrarésistante aux médicaments",
"description": "Comment prévenir la XDR-TB ?\nLe port de masques est-il recommandé ?\nLa vaccination BCG est-elle efficace contre la XDR-TB ?\nLes contacts doivent-ils être testés ?\nLes soins de santé doivent-ils être formés ?",
"url": "https://questionsmedicales.fr/mesh/D054908?mesh_terms=Linear+Models&page=5#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Tuberculose ultrarésistante aux médicaments",
"description": "Quel est le traitement standard pour la XDR-TB ?\nLes médicaments de première ligne sont-ils efficaces ?\nY a-t-il des effets secondaires aux traitements ?\nLa chirurgie est-elle une option de traitement ?\nLes traitements sont-ils coûteux ?",
"url": "https://questionsmedicales.fr/mesh/D054908?mesh_terms=Linear+Models&page=5#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Tuberculose ultrarésistante aux médicaments",
"description": "Quelles sont les complications de la XDR-TB ?\nLa XDR-TB peut-elle causer des infections secondaires ?\nY a-t-il un risque de transmission accrue ?\nLes complications affectent-elles la qualité de vie ?\nLa résistance aux médicaments complique-t-elle le traitement ?",
"url": "https://questionsmedicales.fr/mesh/D054908?mesh_terms=Linear+Models&page=5#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Tuberculose ultrarésistante aux médicaments",
"description": "Quels sont les principaux facteurs de risque ?\nLe tabagisme augmente-t-il le risque ?\nLes personnes âgées sont-elles plus à risque ?\nLes conditions de vie affectent-elles le risque ?\nLes travailleurs de la santé sont-ils à risque ?",
"url": "https://questionsmedicales.fr/mesh/D054908?mesh_terms=Linear+Models&page=5#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer la XDR-TB ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic se fait par culture bactérienne et tests de sensibilité aux antibiotiques."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour la XDR-TB ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests incluent la culture, le test de sensibilité et la PCR pour Mycobacterium tuberculosis."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une XDR-TB ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent toux persistante, fièvre, sueurs nocturnes et perte de poids."
}
},
{
"@type": "Question",
"name": "La radiographie est-elle utile pour la XDR-TB ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la radiographie thoracique peut montrer des lésions pulmonaires caractéristiques."
}
},
{
"@type": "Question",
"name": "Peut-on détecter la XDR-TB par un test rapide ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests rapides comme GeneXpert peuvent détecter la résistance aux médicaments."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes principaux de la XDR-TB ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes principaux sont toux, fièvre, fatigue, et perte d'appétit."
}
},
{
"@type": "Question",
"name": "La douleur thoracique est-elle un symptôme ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la douleur thoracique peut survenir en raison de l'infection pulmonaire."
}
},
{
"@type": "Question",
"name": "Les sueurs nocturnes sont-elles fréquentes ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les sueurs nocturnes sont un symptôme courant de la tuberculose avancée."
}
},
{
"@type": "Question",
"name": "La fatigue est-elle un symptôme de la XDR-TB ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la fatigue persistante est souvent rapportée par les patients atteints de XDR-TB."
}
},
{
"@type": "Question",
"name": "Peut-on avoir des symptômes gastro-intestinaux ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des symptômes comme la diarrhée peuvent survenir, surtout avec des traitements prolongés."
}
},
{
"@type": "Question",
"name": "Comment prévenir la XDR-TB ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention inclut le dépistage précoce, l'isolement des cas et la vaccination BCG."
}
},
{
"@type": "Question",
"name": "Le port de masques est-il recommandé ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le port de masques peut réduire le risque de transmission dans les zones à risque."
}
},
{
"@type": "Question",
"name": "La vaccination BCG est-elle efficace contre la XDR-TB ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "La vaccination BCG offre une protection limitée contre la XDR-TB, mais reste recommandée."
}
},
{
"@type": "Question",
"name": "Les contacts doivent-ils être testés ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les contacts des patients doivent être testés régulièrement pour détecter la tuberculose."
}
},
{
"@type": "Question",
"name": "Les soins de santé doivent-ils être formés ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la formation des professionnels de santé est cruciale pour gérer la XDR-TB efficacement."
}
},
{
"@type": "Question",
"name": "Quel est le traitement standard pour la XDR-TB ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement standard inclut des antibiotiques spécifiques pendant au moins 18 mois."
}
},
{
"@type": "Question",
"name": "Les médicaments de première ligne sont-ils efficaces ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, les médicaments de première ligne ne sont généralement pas efficaces contre la XDR-TB."
}
},
{
"@type": "Question",
"name": "Y a-t-il des effets secondaires aux traitements ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les traitements peuvent causer des effets secondaires comme nausées et hépatotoxicité."
}
},
{
"@type": "Question",
"name": "La chirurgie est-elle une option de traitement ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la chirurgie peut être envisagée pour retirer des lésions pulmonaires dans certains cas."
}
},
{
"@type": "Question",
"name": "Les traitements sont-ils coûteux ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les traitements de la XDR-TB peuvent être très coûteux et nécessitent un suivi régulier."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications de la XDR-TB ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent l'insuffisance respiratoire, la septicémie et la mort."
}
},
{
"@type": "Question",
"name": "La XDR-TB peut-elle causer des infections secondaires ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les patients peuvent développer des infections secondaires en raison d'une immunité affaiblie."
}
},
{
"@type": "Question",
"name": "Y a-t-il un risque de transmission accrue ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la XDR-TB augmente le risque de transmission dans les communautés vulnérables."
}
},
{
"@type": "Question",
"name": "Les complications affectent-elles la qualité de vie ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les complications peuvent gravement affecter la qualité de vie des patients."
}
},
{
"@type": "Question",
"name": "La résistance aux médicaments complique-t-elle le traitement ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la résistance aux médicaments rend le traitement plus long et plus complexe."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent le VIH, la malnutrition, et l'exposition à des cas de tuberculose."
}
},
{
"@type": "Question",
"name": "Le tabagisme augmente-t-il le risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme est un facteur de risque connu pour la tuberculose et ses formes résistantes."
}
},
{
"@type": "Question",
"name": "Les personnes âgées sont-elles plus à risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes âgées ont un risque accru en raison d'un système immunitaire affaibli."
}
},
{
"@type": "Question",
"name": "Les conditions de vie affectent-elles le risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les conditions de vie surpeuplées et insalubres augmentent le risque de XDR-TB."
}
},
{
"@type": "Question",
"name": "Les travailleurs de la santé sont-ils à risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les travailleurs de la santé sont exposés à un risque accru de contracter la XDR-TB."
}
}
]
}
]
}
Motivated by the analysis of longitudinal neuroimaging studies, we study the longitudinal functional linear regression model under asynchronous data setting for modeling the association between clinic...
Stature is one of the significant parameters to confirm a biological profile besides sex, age, and ancestry. Sabah is in the Eastern part of Malaysia and is populated by multi-ethnic groups. To date, ...
The aim is to propose linear models using different hand dimensions (hand span, handbreadth, hand length, middle finger length, and the second inter-crease in the middle finger) for the young adult ma...
This cross-sectional study framework used stratified random sampling on 184 male and 184 female young adults. An unpaired t-test and a one-way ANOVA were used to assess the differences in the mean bet...
The present study demonstrated the highest association for the quantitative explanatory variables among hand length and stature (right side: r = 0.833; left side: r = 0.842). Simple equations were spe...
The study reports anthropometric data and formulas for measuring the stature of major ethnic groups in Sabah, which can be used to compare future work....
Log-linear models are widely used for assessing determinants of fitness in empirical studies, for example, in determining how reproductive output depends on trait values or environmental conditions. S...
Groundwater quality in the Datong basin is threatened by high fluoride contamination. Laboratory analysis is a standard method for estimating groundwater quality parameters, which is expensive and tim...
A connection between the general linear model (GLM) with frequentist statistical testing and machine learning (MLE) inference is derived and illustrated. Initially, the estimation of GLM parameters is...
The presence of Arbuscular Mycorrhizal Fungi (AMF) in vascular land plant roots is one of the most ancient of symbioses supporting nitrogen and phosphorus exchange for photosynthetically derived carbo...
During the aging process, cognitive functions and performance of the muscular and neural system show signs of decline, thus making the elderly more susceptible to disease and death. These alterations,...
This study counted on 99 participants, these were divided into 8 groups, which were grouped by age. The data collection was performed using inertial sensors (positioned on the back of the hand and on ...
The results demonstrated that 125 features are able to distinguish the difference between the groups of young and elderly individuals. The use of the LDA-value allows for the obtaining of a linear mod...
When we compare only the young and elderly groups, the results indicate that there is a difference in the way tasks are performed between young and elderly individuals. When the 8 groups were analyzed...
To analyze the relationship between effective distance and epidemic spread trajectory and between arrival time and scale based on the COVID-19 data outbreak in Wuhan and thus to improve the prediction...
Up to January 28, 2020, the reporting date, the onset date, and the cumulative number of confirmed cases of COVID-19 in each province and city were collected. Baidu migration data was used to calculat...
The linear correlation between the reporting date of the first confirmed patient and the effective distance was not strong. The coefficients of determination (...
The effective distance has a good fit with the model of the onset date of the first confirmed patient and the level of cumulative confirmed cases, which can predict the trajectory, time, and transmiss...
Magnetic resonance imaging (MRI)-guided radiotherapy with multileaf collimator (MLC)-tracking is a promising technique for intra-fractional motion management, achieving high dose conformality without ...
To experimentally compare linear regression (LR) and long-short-term memory (LSTM) motion prediction models for MLC-tracking on an MRI-linac using multiple patient-derived traces with different comple...
Experiments were performed on a prototype 1.0 T MRI-linac capable of MLC-tracking. A motion phantom was programmed to move a target in superior-inferior (SI) direction according to eight lung cancer p...
The end-to-end latency of the system was measured to be (389 ± 15) ms and was successfully mitigated by both LR and LSTM models. The offline+online LSTM was found to outperform the other models for al...
This study represents the first experimental comparison of different prediction models for MRI-guided MLC-tracking using several patient-derived respiratory motion traces. We have shown that among the...
Recently, the utilization of real-world medical data collected from clinical sites has been attracting attention. Especially as the number of variables in real-world medical data increases, causal dis...